Organization · Venture Capital
Pappas Capital
Pappas Capital is a venture capital and commercial development firm based in Durham, North Carolina, specializing in the life sciences sector. The firm invests in biotechnology, biopharmaceuticals, and medical devices, focusing on advancing scientific discoveries from concept to commercialization.
Overview
What Pappas Capital does
What Pappas Capital is
Pappas Capital is a venture capital and commercial development firm based in Durham, North Carolina, specializing in the life sciences sector. The firm invests in biotechnology, biopharmaceuticals, and medical devices, focusing on advancing scientific discoveries from concept to commercialization.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1994
- Approximate age
- About 32 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Pappas Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pappas Capital as a funder
Investment thesis
Pappas Capital focuses on investing in next-generation life science, agriculture, and technology companies, emphasizing translational medicine and company formation through partnerships with academic research institutions.
Focus narrative
Pappas Capital invests primarily in the life science sector, including biotechnology, biopharmaceuticals, drug delivery, and medical devices. The firm targets opportunities across various stages, from seed stage to later-stage mezzanine transactions, with a particular interest in companies at Phase 1 or Phase 2 of development. The organization emphasizes strong proprietary positions, well-defined markets, and effective management teams.
Value beyond capital
Pappas Capital adds value to its portfolio companies through strategic partnerships, particularly with academic institutions, to accelerate the development of innovative technologies. The firm emphasizes company formation and provides operational support to help navigate the complexities of the life sciences sector.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Growth Equity
- Sectors
- Biotech · Healthcare · Agtech · Medical Devices · Digital Health
- Regions
- North AmericaAsiaEurope
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 100
- Recorded notable exits
- CoLucid Pharmaceuticals, Afferent Pharmaceuticals, and Lumena Pharmaceuticals
Portfolio context
Pappas Capital has invested in over 100 companies, including notable portfolio companies such as: Aktis Oncology: Focused on targeted alpha radiopharmaceuticals for treating solid tumor cancers. 4D Molecular Therapeutics: Specializes in next-generation AAV gene therapy products for severe genetic diseases. Achillion Pharmaceuticals: Develops treatments for infectious diseases, including hepatitis C. Aclara Biosciences: Known for innovative microfluidics technology for genetic sequencing. Aer Therapeutics: Focuses on therapeutic solutions for muco-obstructive lung diseases. Amplyx Pharmaceuticals: Develops a new class of antifungal medicine. CuraSen Therapeutics: Works on therapies for neurogenic orthostatic hypotension.
Common questions
What to know about Pappas Capital
Upseed classifies Pappas Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.